NPR: Would A Prize Speed Development Of An Ebola Cure?

Would a prize speed development of treatments? "In the U.S., drugs to treat rare diseases have become lucrative, thanks to tax incentives, special regulatory protection and a willingness by insurers and governments to pay for life-saving treatments. But Ebola, like many other diseases that are mainly a threat in less-developed countries, have been largely neglected by drugmakers....Most Ebola drug research has been financed by the U.S. government, she said, with Canada also pitching in. For Ebola, there may need to be more financial help to get research started and a reward for success." Scott Hensley in NPR.

***

"Theological Implications Of Ebola: Praying For A Cure? Scientifically Creating A Cure?"
http://paxonbothhouses.blogspot.com/2014/08/theological-implications-of-ebola.html